ChristianaCare’s Gene Editing Institute, located in Newark, Delaware, recently announced an innovation that could accelerate CRISPR gene editing work.
Greater Philadelphia Region Celebrates Momentum in Cell and Gene Therapy, Gene Editing, and Connected Health: 2019 in Review
The Greater Philadelphia region’s health care and life sciences community has much to celebrate as 2019 concludes.
As 2019 draws to a close it’s fitting that we take note of the incredible momentum that could be felt across the Greater Philadelphia region’s health care and life sciences community this year, which was also the first year of the Cell & Gene Therapy and Connected Health Initiative.
Leaders from Select Greater Philadelphia and Cozen O'Conner presented at CPhI Worldwide in Frankfurt, Germany, on November 5, 2019 for 45 minutes to an overflowing World of Pharma Podium audience about US regulatory issues and market trends.
For the first time, Greater Philadelphia is recognized as an emerging New World City in JLL’s Global Cities Report for leading the way in innovation in healthcare and life sciences.